Stay updated on GB002 Open-Label Extension in PAH Clinical Trial
Sign up to get notified when there's something new on the GB002 Open-Label Extension in PAH Clinical Trial page.

Latest updates to the GB002 Open-Label Extension in PAH Clinical Trial page
- Check2 days agoChange DetectedThe sponsor/affiliations section was updated to reflect GB002, Inc.'s parent company as Gossamer Bio USA, Inc., replacing references to Gossamer Bio Inc. This change represents a corporate name update for the sponsor organization in the study record.SummaryDifference0.1%

- Check9 days agoChange DetectedThe page content remains the same as in the prior version. No textual changes were detected in the reported update.SummaryDifference0.1%

- Check16 days agoChange DetectedThe page revision label was updated from v3.6.2 to v3.6.3, indicating a small internal update to the study record page.SummaryDifference0.0%

- Check23 days agoChange DetectedRevision label updated from v3.6.0 to v3.6.2, indicating a newer page revision. This appears to be a maintenance update to the page template or content and does not alter study details.SummaryDifference0.0%

- Check38 days agoChange DetectedThe page now includes new help and navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) and displays a recruitment notice indicating no further participant recruitment. Additionally, the Intervention/Treatment header formatting was updated from 'Intervention / Treatment' to 'Intervention/Treatment'.SummaryDifference0.5%

- Check45 days agoChange DetectedThe page's revision label was updated from v3.5.4 to v3.5.5, indicating a minor page update rather than substantive changes to study content.SummaryDifference0.0%

Stay in the know with updates to GB002 Open-Label Extension in PAH Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GB002 Open-Label Extension in PAH Clinical Trial page.